302 related articles for article (PubMed ID: 28706852)
1. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
[TBL] [Abstract][Full Text] [Related]
2. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Genovese AV; Hojnacki D; Weinstock-Guttman B; Dwyer MG
Neuroimage Clin; 2021; 29():102554. PubMed ID: 33472143
[TBL] [Abstract][Full Text] [Related]
3. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.
Barnett M; Bergsland N; Weinstock-Guttman B; Butzkueven H; Kalincik T; Desmond P; Gaillard F; van Pesch V; Ozakbas S; Rojas JI; Boz C; Altintas A; Wang C; Dwyer MG; Yang S; Jakimovski D; Kyle K; Ramasamy DP; Zivadinov R
Neuroimage Clin; 2021; 32():102802. PubMed ID: 34469848
[TBL] [Abstract][Full Text] [Related]
4. Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis.
Dwyer MG; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Barnett MH; Wang C; Tomic D; Silva D; Zivadinov R
J Neuroimaging; 2019 Sep; 29(5):615-623. PubMed ID: 31259467
[TBL] [Abstract][Full Text] [Related]
5. Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset.
Jakimovski D; Zivadinov R; Bergsland N; Oh J; Martin M; Shinohara RT; Bakshi R; Calabresi PA; Papinutto N; Pelletier D; Dwyer MG
J Neuroimaging; 2022 Sep; 32(5):910-919. PubMed ID: 35384119
[TBL] [Abstract][Full Text] [Related]
6. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.
Ghione E; Bergsland N; Dwyer MG; Hagemeier J; Jakimovski D; Paunkoski I; Ramasamy DP; Silva D; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2237-2242. PubMed ID: 30467212
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
Zivadinov R; Bergsland N; Korn JR; Dwyer MG; Khan N; Medin J; Price JC; Weinstock-Guttman B; Silva D;
AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
[TBL] [Abstract][Full Text] [Related]
8. DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis.
Dwyer M; Lyman C; Ferrari H; Bergsland N; Fuchs TA; Jakimovski D; Schweser F; Weinstock-Guttmann B; Benedict RHB; Riolo J; Silva D; Zivadinov R
Neuroimage Clin; 2021; 30():102652. PubMed ID: 33872992
[TBL] [Abstract][Full Text] [Related]
9. Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis.
Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Weinstock-Guttman B; Kolb C; Hojnacki D; Dwyer MG
J Neuroimaging; 2020 May; 30(3):342-350. PubMed ID: 32392376
[TBL] [Abstract][Full Text] [Related]
10. Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study.
Jakimovski D; Silva D; Niels Bergsland ; Dwyer MG; Weinstock-Guttman B; Benedict RH; Riolo J; Zivadinov R;
Mult Scler Relat Disord; 2023 Jun; 74():104708. PubMed ID: 37084495
[TBL] [Abstract][Full Text] [Related]
11. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
[TBL] [Abstract][Full Text] [Related]
12. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.
Zivadinov R; Khan N; Medin J; Christoffersen P; Price J; Korn JR; Bonzani I; Dwyer MG; Bergsland N; Carl E; Silva D; Weinstock-Guttman B
J Neuroimaging; 2017 May; 27(3):339-347. PubMed ID: 27918139
[TBL] [Abstract][Full Text] [Related]
13. Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI.
Fuchs TA; Dwyer MG; Jakimovski D; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Hb Benedict R; Zivadinov R
Neuroimage Clin; 2021; 31():102705. PubMed ID: 34091352
[TBL] [Abstract][Full Text] [Related]
14. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
[TBL] [Abstract][Full Text] [Related]
15. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
[TBL] [Abstract][Full Text] [Related]
17. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
[TBL] [Abstract][Full Text] [Related]
18. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
[TBL] [Abstract][Full Text] [Related]
19. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
20. Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.
Jakimovski D; Weinstock-Guttman B; Gandhi S; Guan Y; Hagemeier J; Ramasamy DP; Fuchs TA; Browne RW; Bergsland N; Dwyer MG; Ramanathan M; Zivadinov R
J Neurol; 2019 Apr; 266(4):866-875. PubMed ID: 30758665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
